Teneligliptin 20mg

DRUG3 trials

Sponsors

Tanabe Pharma Corporation, Handok Inc.

Conditions

Type 2 Diabetes Mellitus

Phase 3

Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus

CompletedNCT02916706

Tanabe Pharma CorporationType 2 Diabetes Mellitus

Start: 2016-09-30Updated: 2026-01-06

Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus

CompletedNCT02924064

Tanabe Pharma CorporationType 2 Diabetes Mellitus

Start: 2016-09-30Updated: 2026-01-06

Unknown Phase

Observational Study to Evaluate the Efficacy and Safety of Teneligliptin

CompletedNCT03793023

Handok Inc.Type 2 Diabetes Mellitus

Start: 2016-01-05End: 2019-09-23Updated: 2025-01-27

Related Papers

Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report.

2019-05-115 citations